Gainplan LLC Sarepta Therapeutics, Inc. Transaction History

Gainplan LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$82.38 - $131.64 $247,140 - $394,919	-3,000 Closed	0 $0
Q4 2019 Jan 15, 2020	BUY	$76.53 - $135.58 $229,590 - $406,740	3,000 New	3,000 $387,000
Q3 2019 Nov 05, 2019	SELL	$72.81 - $156.91 $145,620 - $313,820	-2,000 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$112.21 - $151.95 $224,420 - $303,900	2,000 New	2,000 $304,000
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $461,240 - $646,040	-4,000 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$71.74 - $153.69 $286,960 - $614,760	4,000 New	4,000 $529,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Gainplan LLC, based on Form 13F filings with the SEC.

Stay updated on Gainplan LLC with notifications on news.